Furthermore, our analysis of human cancer sequencing data revealed better overall patient survival and more tumor infiltration by CD8+ T cells in individuals with high expression of DEPDC5, which this study has identified as an anti-ferroptosis gene (Fig. 1b, c). This evidence concerns the gene DEPDC5 and cancer.